🔗 Share this article

Acclaimed soul vocalist D’Angelo passed away on October 14 at 51 years old after a personal fight with pancreatic malignancy.

“The brilliant light of our household has dimmed his light for us in this life,” his relatives confirmed. “After a lengthy and courageous battle with cancer, we are deeply saddened to declare that D’Angelo, known to his followers around the globe as D’Angelo, has been taken from us.”

D’Angelo made a lasting impact on music with his innovative neo-soul sound and partnerships with renowned musicians.

He launched his first record, “Brown Sugar,” in 1995 to immediate acclaim. The album achieved the fourth spot on Billboard’s Top R&B Albums chart, went platinum soon after, and earned several award nominations.

However, it was his second album, “Voodoo,” in the year 2000 that boosted his music career into the stratosphere. The album premiered at the top spot on both Billboard’s Top R&B Albums chart and the Billboard 200. He received two Grammys: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s standing as a sex symbol, albeit a reluctant one, in the cultural zeitgeist. The intimate portrayal showed the singer, famously stripped down to his midsection, singing straight into the camera.

D’Angelo retreated from the public eye after putting out Voodoo and openly battled with drugs and alcohol. In 2005, he was involved in a severe car crash that left him in critical condition.

Over ten years later, his last record, “Black Messiah” (2014), confirmed his enduring appeal with a further top chart entry on the soul music rankings and a Grammy for Best R&B Album.

Again, in his own enigmatic way, D’Angelo made only a few public appearances in the subsequent period.

The musician was scheduled as a top act for the 2025 Roots Picnic festival, but his appearance was called off, citing an “unexpected health issue.”

Although details are sparse about D’Angelo’s well-being in the months leading up to his death, he had apparently been in the hospital for an extended period and in hospice for two weeks.

D’Angelo’s demise is a clear example of the harmful impact of pancreatic malignancy, one of the most deadly and least preventable types of the disease, on a brilliant talent whose existence was cut short.

“We are grieved that he can only leave cherished moments with his loved ones, but we are forever thankful for the legacy of deeply emotional songs he leaves behind,” his family expressed.

Pancreatic Cancer: Lethal and Difficult to Avoid

Pancreatic malignancy impacts the pancreas, a tiny gland that produces the hormone insulin and is vital in breaking down food, among additional roles. The position and dimensions of the organ in the body make it more challenging to identify malignancy.

Even though this cancer makes up only approximately three percent of cancer diagnoses each year in the U.S., it is causes seven percent of cancer deaths.

Almost 70,000 individuals will be found to have this condition and about 52,000 will die of the disease in 2025.

“This malignancy is one of the most lethal diseases, with an aggressive tumor and dismal outcomes. We have few and ineffective therapies, and a narrow opportunity to make a meaningful impact on the well-being of patients,” noted a medical oncologist.

Since this disease rarely causes early symptoms, it’s frequently diagnosed only after the disease is advanced. Although a patient has symptoms they are often nonspecific and may be mistaken for a several everyday ailments.

“Currently, there is no good way to identify pancreatic cancer in the initial phases, except for paying attention to physical changes and speaking with your physician if there are new or unusual signs,” said a medical director.

Frequent indicators of this disease include:

• abdominal or lower back pain
• reduced body mass
• jaundice
• loss of appetite
• dark urine
• light-colored or greasy stools
• loose stools
• increased appetite or thirst
• nausea

At age 51, D’Angelo’s demise is an outlier, as this malignancy is most common in individuals in the sixty-five to seventy-five range. However, many cancers, including pancreatic cancer, have become more common in younger people.

“Pancreatic cancer identified before the age of 50 is deemed uncommon, yet alarmingly, clinicians are noticing a rising count of younger patients affected by this disease,” said a expert.

Genetic Background Impacts Cancer Risk

In the absence of effective screening tools for this malignancy, professionals stressed the importance of knowing your family’s health background. Certain risk factors, such as smoking and excess weight also play a role in the development of pancreatic cancer.

Black individuals have the greatest occurrence of pancreatic cancer in the U.S. and are more prone to be found to have untreatable disease.

“The first step toward reducing one’s risk of pancreatic cancer is assessing personal risk factors. Individuals should examine their family history, genetic background, and health issues, such as diabetes, chronic pancreatitis, or overweight that may increase their vulnerability,” advised a medical professional.

Hereditary elements are linked to as much as ten percent of all pancreatic cancer cases. If a relative in your household has had this disease, you may want to consider genetic testing.

“For people with a family history of this condition or those having elevated risk DNA changes, checking may involve advanced imaging such as MRI scans or internal ultrasound to detect early changes in the pancreas,” he clarified.

For those looking to reduce their risk, habit adjustments may have an effect. The best action you can take to reduce your susceptibility of this disease is to stop tobacco use, and if you don’t smoke, stay away altogether.

Excessive alcohol consumption is associated with pancreatitis, a risk factor for pancreatic cancer, so limiting or avoiding alcohol may help reduce your risk.

Managing your body mass or losing weight may also aid decrease your susceptibility. Individuals with excess weight are 20% more likely to get this disease. This malignancy also is more frequent in those with diabetes, and reducing weight can also lower the risk of adult-onset diabetes.

In spite of pancreatic cancer’s poor prognosis, there is reason for optimism.

“We are making progress with therapies and newer mixed drug treatments. There are developing targeted therapies that already are showing results,” remarked a specialist.

For many individuals, however, awareness about this uncommon but {dev